Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice

Journal of Ethnopharmacology

Volumn 126, Issue 3, 2009, Pages 415-420

  Zhao, Ruizhi ^a   Liu, Shaojun ^a   Mao, Shirui ^b   Wang, Yanjun ^b  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Distribution; Liver target; Pharmacokinetics; Resveratrol; Vinegar baked Radix Bupleuri

Indexed keywords

BUPLEURUM ROOT EXTRACT; RESVERATROL; VINEGAR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG POTENTIATION; DRUG RETENTION; DRUG TARGETING; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN;

ACETIC ACID; ANIMALS; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; LIVER; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; STILBENES; TISSUE DISTRIBUTION;

MUS;

EID: 70449646164     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.09.023     Document Type: Article

References (31)

1. Ahn B.-Z., Yoom Y.-D., Lee Y.H., et al. Inhibitory effect of Radix Bupleuri saponins on adhesion of some solid tumor cells and relation to hemolytic action: screening of 22 herbal drugs for anti-cell adhesion. Planta Medicine 64 (1998) 220-224
2. Ai S. Radix of polygonum cuspidatum as main drug treat hepatitis A. Zhongguo Minzu Minjian Yiyao Zazhi 5 (2002) 273-275
3. Banerjee S., Bueso-Ramos C., and Aggarwal B.B. Suppression of 7,12 dimethylbenz(a) anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research 62 (2002) 4945-4954
4. Chun Y.J., Kim M.Y., and Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochemistry and Biophysics Research Communications 262 (1999) 20-24
5. Guengerich F.P., Chun Y.J., Kim D., Gillam E.M.J., and Shimada T. Cytochrome P4501B1: a target for inhibition in anticarcinogenesis strategies. Mutation Research 523-524 (2003) 173-182
6. Gupta P.K., and Hung C.T. Quantitative evaluation of targeted drug delivery system. International Journal of Pharmaceutics 56 (1989) 217-226
7. Gusman J., Malonne H., and Atassi G. A re-appraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22 (2001) 1111-1117
8. Haworth R.S., and Avkiran M. Inhibition of protein kinase D by resveratrol. Biochemical Pharmacology 62 (2001) 1647-1651
9. Jang M., Cai L., Udeani G., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
10. Li X.D. Comparative analysis of active composition of Radix Bupleuri before and after being processed. Zhong YI Yao Xuebao 22 (2000) 483-484
11. Li Z.G., Hong T., Shimada Y., Komoto I., et al. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23 (2002) 1531-1536
12. Liu Y. Application analysis of meridian guide drug in compound of Traditional Chinese Medicine. Hubei Zhongyi Zazhi 26 (2004) 39-40
13. Mahyar-Roemer M., Katsen A., Mestres P., and Roemer K. Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. International Journal of Cancer 94 (2001) 615-622
14. Matsumoto T., Moriya M., and Sakurai M.H. Stimulatory effect of a pectic polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L., on G-CSF secretion from intestinal epithelial cells. International Immunopharmacology 8 (2008) 581-588
15. Moses M.A., Brem H., and Langer R. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 4 (2003) 337-341
16. Nie S.Q., Yang Q., Li L.F., and Huang L.Q. Pharmacodynamics comparison of Bupleurum root and red peony root, vinegar-baked Bulpeurum root and whie peony root between compatibility and single application. Shiyan Fangji Xue Zazhi 8 (2002) 11-14
17. Nie S., Liu X., Chen S., and Li K. Studies on fingerprints of Bupleurum Chinese and vinegar-baked Bupleurum Chinese from Hubei province. Zhong Yao Cai 31 (2008) 657-659
18. Peek L.J., Middaugh C.R., and Berkland C. Nanotechnology in vaccine delivery. Advances in Drug Delivery Reviews 60 (2008) 915-928
19. Rivera E., Valero V., Esteva F.-J., et al. Lack activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer. Cancer Chemother. Pharmacol. 49 (2002) 299-302
20. Sale S., Verschoyle1 R.D., Boocock D., et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,40-tetramethoxystilbene. British Journal of Cancer 90 (2004) 736-744
21. Sams-Dodd F. Target-based drug discovery: is something wrong?. Drug Delivery Today 10 (2005) 139-147
22. Schneider Y., Vincent F., Duranton B., Badolo L., Gosse F., Bergmann C., Seiler N., and Raul F. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Letters 158 (2000) 85-91
23. Sgambato A., Ardito R., Faraglia B., et al. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutation Research: General Toxicology and Environmental Mutagenesis 496 (2001) SI171-SI180
24. Subbaramaiah K., Chung W.J., Michaluart P., et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal Biological Chemistry 273 (1998) 21875-21882
25. Surh Y.J., Chun K.S., Cha H.H., et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutation Research 480-481 (2001) 243-268
26. Wenzel E., and Somoza V. Metabolism and bioavailability of trans-resveratrol. Molecular Nutrition and Food Research 49 (2005) 472-481
27. Wolter F., Akoglu B., Clausnitzer A., and Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. Journal of Nutrition 131 (2001) 2197-2203
28. Wu J. Effect of process on components and pharmacological of Radix Bupleurum. Hubei Zhongyi Zazhi 30 (2008) 60-61
29. Yin Y.C., and Liu J.B. Polygonum cuspidatum, Pueraria lobata, and Radix Bupleuri coadministered with Siwu docation treated chronic active hepatitis 108 case. Shanxi Zhongyi 19 (1998) 97-98
30. Yu C., Shin Y.G., Chow A., Li Y., et al. Human, rat and mouse metabolism of resveratrol. Pharmaceutical Research 19 (2002) 1907-1914
31. Zhao R.Z., and Liu S.J. TCM medicinal guide theory and target-tropism administration. Zhong Yi Za Zhi 46 (2005) 643-645